Logo image
Sign in
Part C of a phase I/II study evaluating single agent rinatabart sesutecan in patients with advanced and/or metastatic platinum-resistant ovarian cancer
Journal article   Peer reviewed

Part C of a phase I/II study evaluating single agent rinatabart sesutecan in patients with advanced and/or metastatic platinum-resistant ovarian cancer

Elizabeth Lee, Justin Call, Ira Winer, Oladapo Yeku, Debra Richardson, Leigh Seamon, Erika Hamilton, Noelle Cloven, Jian Zhang, Edward Kavalerchik, …
Gynecologic oncology, Vol.200, pp.112-113
09/2025

Metrics

3 Record Views

Details

Logo image